Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
tofacitinib (xeljanz) (1 trial)
isobutylamido-thiazolyl-resorcinol (1 trial)
Alopecia (Phase 4)
Alopecia Areata (Phase 4)
Facies (Phase 3)
Hyperpigmentation (Phase 3)
Trials (2 total)
Trial APIs (2 total)